Data as of May 21
| -1.43 / -1.52%|
The 17 analysts offering 12-month price forecasts for Onyx Pharmaceuticals Inc have a median target of 106.00, with a high estimate of 132.00 and a low estimate of 98.00. The median estimate represents a +14.09% increase from the last price of 92.91.
The current consensus among 21 polled investment analysts is to Buy stock in Onyx Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.